Literature DB >> 32836076

Vitamin C: A stem cell promoter in cancer metastasis and immunotherapy.

Jingwen Fu1, Zhaoyi Wu1, Jianfeng Liu2, Tianfu Wu3.   

Abstract

Vitamin C is an electron donor and is involved in a variety of biochemical reactions in stem cell and cancer stem cell, as well as collagen synthesis and the regulation of hypoxia-inducible factor synthesis, which two affect extracellular matrix remodelling and hence cancer metastasis. Specific doses of vitamin C can stop cancer cell glycolysis and block nitroso synthesis, indicating the potential of vitamin C in cancer treatment. Recent studies preliminary revealed Vitamin C enhance the cancer's immune response to anti PD-L1 therapy through multiple indirect approaches. Herein we reviewed the recent function of vitamin C for further research in sequential aspects of cancer stem cell, extracellular matrix remodeling, cancer metastasis and cancer immunotherapy.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cancer metastasis; Cancer therapy; Extracellular matrix remodeling; Hypoxic induction factory; Immune system; Vitamin C

Mesh:

Substances:

Year:  2020        PMID: 32836076     DOI: 10.1016/j.biopha.2020.110588

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

Review 1.  Effect of vitamins C and E on cancer survival; a systematic review.

Authors:  Ozra Tabatabaei-Malazy; Leila Azadbakht; Shahrzad Mohseni; Hanieh-Sadat Ejtahed; Mostafa Qorbani; Patricia Khashayar; Bagher Larijani
Journal:  Daru       Date:  2022-09-22       Impact factor: 4.088

2.  Antioxidant Properties and Aldehyde Reactivity of PD-L1 Targeted Aryl-Pyrazolone Anticancer Agents.

Authors:  Natascha Leleu-Chavain; Romain Regnault; Hania Ahouari; Raphaël Le Biannic; Mostafa Kouach; Frédérique Klupsch; Romain Magnez; Hervé Vezin; Xavier Thuru; Christian Bailly; Jean-François Goossens; Régis Millet
Journal:  Molecules       Date:  2022-05-21       Impact factor: 4.927

Review 3.  Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation.

Authors:  Mengling Wu; Qianrui Huang; Yao Xie; Xuyi Wu; Hongbo Ma; Yiwen Zhang; Yong Xia
Journal:  J Hematol Oncol       Date:  2022-03-12       Impact factor: 17.388

Review 4.  Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis.

Authors:  Ana Hipólito; Filipa Martins; Cindy Mendes; Filipa Lopes-Coelho; Jacinta Serpa
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.